Need professional-grade analysis? Visit stockanalysis.com
$104.56M
N/A
N/A
N/A
Turn Therapeutics Inc. Common Stock (TTRX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $3.35, down 3.18% from the previous close.
Over the past year, TTRX has traded between a low of $2.71 and a high of $9.20. The stock has lost 52.1% over this period. It is currently 63.6% below its 52-week high.
Turn Therapeutics Inc. Common Stock has a market capitalization of $104.56M.
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Side-by-side comparison against top Healthcare peers.